chlormadinone acetate has been researched along with Prostatic Neoplasms in 101 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (26.73) | 18.7374 |
| 1990's | 43 (42.57) | 18.2507 |
| 2000's | 27 (26.73) | 29.6817 |
| 2010's | 3 (2.97) | 24.3611 |
| 2020's | 1 (0.99) | 2.80 |
| Authors | Studies |
|---|---|
| Akaza, H; Hirao, Y; Horie, S; Kakehi, Y; Sugimoto, M | 1 |
| Ando, N; De Velasco, MA; Fukushima, E; Hatanaka, Y; Koike, H; Kura, Y; Nishio, K; Nozawa, M; Uemura, H; Yamamoto, Y; Yoshikawa, K | 1 |
| Hakariya, H; Hara, T; Hayashi, M; Igawa, T; Iwasaki, S; Kanetake, H; Kusaba, Y; Sakai, H; Tsurusaki, T; Yura, M | 1 |
| Deguchi, T; Ehara, H; Fujihiro, S; Fujimoto, Y; Hagiwara, N; Kamei, S; Kanimoto, Y; Katoh, S; Katoh, T; Kojima, K; Nakane, K; Takada, T; Takahashi, Y; Yuhara, K | 1 |
| Higashihara, E; Nutahara, K; Okegawa, T | 1 |
| Kobayashi, M; Kurokawa, S; Morita, T; Nukui, A; Suzuki, K | 1 |
| Kiriyama, I; Nishimura, T; Ogaki, K; Ohba, S | 1 |
| Mizokami, A; Namiki, M | 1 |
| Akaza, H; Aso, Y; Hirao, Y; Homma, Y; Ohashi, Y; Okada, K; Tsushima, T; Usami, M; Yokoyama, M | 1 |
| Furuya, Y; Fuse, H; Nagakawa, O | 1 |
| Igaki, H; Kaizu, T; Karasawa, K; Matsuda, T; Niibe, Y; Shinohara, M; Tanaka, Y | 1 |
| Akashi, T; Furuya, Y; Fuse, H; Ohta, S | 1 |
| Akaza, H; Aso, Y; Hirao, Y; Homma, Y; Ohashi, Y; Okada, K; Sakamoto, A; Tsushima, T; Usami, M; Yokoyama, M | 1 |
| Akaza, H; Aso, Y; Hirao, Y; Homma, Y; Moriyama, N; Ohashi, Y; Okada, K; Sakamoto, A; Tsushima, T; Usami, M; Yokoyama, M | 3 |
| Kondo, Y; Kunimoto, K; Nishimura, T; Saito, Y; Shimizu, H | 1 |
| Fujimoto, H; Fukui, I; Harada, M; Ito, K; Kakizoe, T; Kotake, T; Matsuoka, N; Naito, S; Ohashi, Y; Tsukamoto, T; Usami, M; Yamanaka, H | 1 |
| Kobayashi, M; Morita, T; Nukui, A | 1 |
| Fujikawa, N; Murai, T; Noguchi, K; Saito, K; Teranishi, J; Uemura, H | 1 |
| Gotanda, K; Goya, N; Okada, M; Sasaki, T; Toma, H; Tomizawa, Y | 1 |
| Akaza, H | 1 |
| Hasegawa, Y; Masue, N | 1 |
| Furuya, R; Furuya, S; Hisasue, S; Ogura, H; Saitoh, N; Takahashi, S; Tsukamoto, T | 1 |
| Arita, J; Higuchi, T; Kawakami, M; Nishimura, R; Noguchi, K; Takai, S | 1 |
| Shida, K | 1 |
| Matsuoka, M; Mayuzumi, T; Shida, K | 1 |
| Chen, YS; Chen, YX; Zhang, SS; Zhang, TJ | 1 |
| Nishimura, R; Shida, K | 1 |
| Morita, I | 1 |
| Kawai, T; Kusuyama, H; Takahashi, T; Washizuka, M | 1 |
| Hasegawa, F; Isurugi, K; Takahashi, S | 1 |
| Ezaki, K; Hayahara, N; Iritani, M; Kashihara, N; Maekawa, T; Morikawa, Y; Nishijima, T; Senju, M; Tsujita, M; Yamaguchi, M | 1 |
| Akimoto, S; Ichikawa, T; Shimazaki, J | 1 |
| Akakura, K; Akimoto, S; Ohki, T; Shimazaki, J | 1 |
| Takeuchi, S; Yoshida, K | 1 |
| Akaza, H; Kawai, K; Koiso, K; Sekido, N | 1 |
| Kinouchi, T; Kotake, T; Kuroda, M; Maeda, O; Meguro, N; Saiki, S; Usami, M | 1 |
| Kawai, T; Kawakami, S; Ohno, Y; Tachibana, Y; Ueda, T; Yamauchi, T; Yonese, J | 1 |
| Akaza, H; Aso, Y; Koiso, K; Kotake, T; Usami, M | 1 |
| Kanetake, H | 1 |
| Fukui, I; Goto, S; Kihara, K; Kitahara, S; Kobayashi, T; Kojima, S; Oshima, H; Tsukamoto, T | 1 |
| Fujii, A; Gohji, K; Morisue, K; Nomi, M; Okamoto, M | 1 |
| Aida, S; Akakura, K; Akimoto, S; Komiya, A; Shimazaki, J; Suzuki, H | 1 |
| Iwasawa, T; Matsumoto, H | 1 |
| Arai, K; Honda, M; Hosoya, Y; Imai, T; Koga, F; Maeda, S; Sumi, S; Suzuki, T; Umeda, H; Yano, M; Yoshida, K | 1 |
| Nukui, F | 1 |
| Akakura, K; Akimoto, S; Inomiya, H; Ito, H; Shimazaki, J | 1 |
| Hasumi, M; Nakata, S; Ogawa, A; Sato, J; Yamanaka, H | 1 |
| Akakura, K; Akimoto, S; Furuya, Y; Igarashi, T; Ito, H; Murakami, S; Shimazaki, J | 1 |
| Akahane, H; Fukuda, M; Inoue, Y; Matsuzaki, J; Miyoshi, Y; Saito, S; Satomi, Y | 1 |
| Akakura, K; Akimoto, S; Furuya, Y; Inomiya, H; Ito, H | 1 |
| Akakura, K; Akimoto, S; Furuya, Y; Ito, H | 1 |
| Akakura, K; Furuya, Y; Ito, H | 1 |
| Hirao, Y; Ozono, S | 1 |
| Fuji, K; Hamajima, T; Higaki, Y; Hiramori, M; Hoshino, M; Ikeuchi, T; Inoue, K; Kai, Y; Kasahara, T; Matsuda, N; Ogawa, Y; Shimada, M; Uchida, H; Yoshida, H | 1 |
| Kagawa, S; Kanayama, H; Miyake, N; Sumiyoshi, Y; Yamamoto, A; Yokozeki, H | 2 |
| Itoh, K; Kubota, Y; Nakada, T; Sasagawa, I; Suzuki, H; Yanai, H | 1 |
| Honda, M; Hosoya, Y; Kitahara, S; Koga, F; Moriguchi, H; Sumi, S; Umeda, H; Yano, M; Yoshida, K | 1 |
| Akaza, H; Aso, Y; Hirao, Y; Homma, Y; Isaka, S; Kanetake, H; Kawabe, K; Koiso, K; Kotake, T; Kumazawa, J; Naito, S; Ohashi, Y; Ohi, Y; Okajima, E; Orikasa, S; Saito, Y; Shimazaki, J; Usami, M; Yoshida, O | 1 |
| Ito, H; Kotake, T; Masai, M; Sakai, S; Sato, N | 1 |
| Hamano, S; Kinsui, H; Murakami, S; Oikawa, T; Shimazaki, J; Suzuki, N; Tanaka, M | 1 |
| Akaza, H; Aso, Y; Hirao, Y; Homma, Y; Moriyama, N; Ohashi, Y; Okada, K; Tsushima, T; Usami, M; Yokoyama, M | 1 |
| Harada, M; Hosaka, M; Kawasaki, C; Kinoshita, Y; Kondo, I; Miura, T; Noguchi, K; Ohuchi, H | 1 |
| Ito, K; Kurokawa, K; Shiono, A; Yamanaka, H | 1 |
| Hirao, Y; Iwai, A; Maruyama, Y; Moriya, A; Okajima, E; Ozono, S; Samma, S; Yamaguchi, A; Yoshida, K; Yoshikawa, M | 1 |
| Fujimoto, N; Harada, S; Hida, T; Matsumoto, T | 1 |
| Ichijo, K; Mugiya, S; Nagae, H; Nagata, M; Sato, T; Un-no, T | 1 |
| Furuya, Y; Fuse, H; Nagakawa, O; Nozaki, T | 1 |
| Walsh, PC | 1 |
| Ito, Z; Kitaura, K; Kurosawa, K; Shida, K; Yamanaka, H | 1 |
| Katayama, T; Shimazaki, J | 1 |
| Hosaka, M; Kimihira, A; Konno, M; Mamiya, N; Nishimura, R | 2 |
| Hashizume, Y; Koike, Y; Sakurai, N; Takahashi, A | 1 |
| Akimoto, M; Yoshida, K | 1 |
| Akimoto, S; Higa, T; Isaka, S; Masai, M; Shimazaki, J | 1 |
| Ishizu, K; Joko, K; Konishi, M; Sakatoku, J; Takihara, H; Tanaka, K | 1 |
| Akimoto, S; Isaka, S; Masai, M; Shimazaki, J; Yatani, R | 1 |
| Chino, I; Hayashi, N; Imamura, H; Kimura, M; Kudo, K; Matsuyama, K; Mimura, H; Nagata, M; Shishido, S | 1 |
| Takai, K | 1 |
| Fujita, K; Matsushima, H; Munakata, A; Ueki, T; Yamazaki, S | 1 |
| Imai, K; Masimo, T; Suzuki, T; Yamanaka, H | 1 |
| Kobayashi, H; Murase, T; Obata, K; Ohisi, M | 1 |
| Fujii, A; Higuchi, A; Itoh, N; Miyasaki, S; Morishita, S; Oka, N; Okamoto, Y; Tanaka, H; Tomioka, O; Yamanaka, K | 1 |
| Fujii, A; Kawaida, T; Nakamura, I; Yasuno, H | 1 |
| Fukuoka, H; Goto, A; Moriyama, M; Murai, T; Nakao, H; Satomi, Y; Senga, Y; Shirai, K | 1 |
| Ikemoto, I; Machida, T | 1 |
| Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
| Hayashi, T; Hiura, M; Ikai, K; Kiriyama, T; Taki, Y | 1 |
| Aso, Y; Kakizoe, T; Kishi, K; Ohtani, M; Sato, S; Takai, K; Tobisu, K | 1 |
| Akakura, K; Akimoto, S; Fuse, H; Shimazaki, J; Yatani, R | 1 |
| Labrie, F; Lapointe, S; Plante, M | 1 |
| Katayama, T; Sasagawa, I; Satomi, S | 1 |
| Hayashi, T; Hiura, M; Kiriyama, T; Ryoji, O; Takenawa, J; Taki, Y | 1 |
| Nomura, S; Saito, K; Takahashi, T | 1 |
| Neumann, F; Steinbeck, H | 1 |
| Frick, J; Marberger, H; Swoboda, HP | 1 |
| Popelier, G | 1 |
| Fruchtman, B; Geller, J; Meyer, C; Newman, H | 1 |
11 review(s) available for chlormadinone acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
[Total androgen blockade].
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Castration; Chlormadinone Acetate; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nitriles; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds | 2002 |
Rotational 3D-conformal radiation therapy (conformation therapy) combined with hormone therapy for the treatment of stage B2/C prostate cancer in Japanese men.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Chlormadinone Acetate; Diethylstilbestrol; Disease-Free Survival; Flutamide; Follow-Up Studies; Gastrointestinal Diseases; Goserelin; Humans; Imaging, Three-Dimensional; Japan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prostatic Neoplasms; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Retrospective Studies; Rotation; Survival Analysis; Treatment Outcome; Urination Disorders | 2003 |
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Gonadotropin-Releasing Hormone; Humans; Japan; Leuprolide; Male; Neoplasm Staging; Nitriles; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds | 2007 |
[Fundamental and clinical study on antiandrogens--androgen-dependency of prostatic tumors and clinical application of antiandrogens (author's transl)].
Topics: Aged; Androgen Antagonists; Animals; Chlormadinone Acetate; Clinical Trials as Topic; Humans; Hydroxytestosterones; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats | 1980 |
[Application of antiandrogens on prostatic diseases].
Topics: Androgen Antagonists; Chlormadinone Acetate; Clinical Trials as Topic; Flutamide; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms | 1994 |
[Progress of endocrine therapy for prostate cancer and results].
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Estrogens; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Multivariate Analysis; Orchiectomy; Prognosis; Prostatic Neoplasms; Survival Rate | 1996 |
[A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation].
Topics: Adenocarcinoma; Androgen Antagonists; Cell Differentiation; Chlormadinone Acetate; Humans; Male; Middle Aged; Neurosecretory Systems; Progesterone Congeners; Prostatic Neoplasms | 1998 |
[Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
Topics: Androgen Antagonists; Anilides; Chlormadinone Acetate; Flutamide; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Hyperplasia; Prostatic Neoplasms; Tosyl Compounds | 1998 |
[Total androgen blockade--concept, theory, method and clinical application].
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1998 |
[Step up therapy].
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Diethylstilbestrol; Drug Administration Schedule; Humans; Male; Middle Aged; Prostatic Neoplasms | 2000 |
[Anti-androgens. Animal experiments and clinical application].
Topics: Acetates; Androgen Antagonists; Animals; Bone and Bones; Chlormadinone Acetate; Disorders of Sex Development; Dogs; Feedback; Female; Fertility; Humans; Hydroxyprogesterones; Libido; Male; Mice; Progestins; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Drug; Sebaceous Glands; Spermatozoa | 1971 |
25 trial(s) available for chlormadinone acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study.
Topics: Androgen Antagonists; Chlormadinone Acetate; Double-Blind Method; Humans; Japan; Male; Prostatic Neoplasms | 2022 |
Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Leuprolide; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Quality of Life; Steroids; Tosyl Compounds | 2009 |
A prospective and randomized study of primary hormonal therapy for patients with localized or locally advanced prostate cancer unsuitable for radical prostatectomy: results of the 5-year follow-up.
Topics: Aged; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Recurrence, Local; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer.
Topics: Age Factors; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Humans; Leuprolide; Male; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Survival Rate | 2004 |
Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Chlormadinone Acetate; Disease-Free Survival; Drug Therapy, Combination; Humans; Leuprolide; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Treatment Outcome | 2004 |
Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Brachytherapy; Chlormadinone Acetate; Combined Modality Therapy; Disease-Free Survival; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Treatment Outcome | 2005 |
[Fundamental and clinical study on antiandrogens--androgen-dependency of prostatic tumors and clinical application of antiandrogens (author's transl)].
Topics: Aged; Androgen Antagonists; Animals; Chlormadinone Acetate; Clinical Trials as Topic; Humans; Hydroxytestosterones; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats | 1980 |
Antiandrogenic therapy for the treatment of early stage prostatic cancer.
Topics: Androgen Antagonists; Chlormadinone Acetate; Clinical Trials as Topic; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1981 |
[Endocrine chemotherapy for prostatic cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Follow-Up Studies; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1994 |
Pretreatment with chlormadinone acetate eliminates testosterone surge induced by a luteinizing-hormone-releasing hormone analogue and the risk of disease flare in patients with metastatic carcinoma of the prostate.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma; Chlormadinone Acetate; Disease Progression; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Male; Middle Aged; Premedication; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1995 |
Preoperative endocrine therapy in patients with locally advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Chlormadinone Acetate; Diethylstilbestrol; Estramustine; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Prostatectomy; Prostatic Neoplasms | 1995 |
A randomized phase II trial of flutamide vs chlormadinone acetate in previously untreated advanced prostatic cancer. The Japan Flutamide Study Group.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Chlormadinone Acetate; Confidence Intervals; Double-Blind Method; Flutamide; Follow-Up Studies; Hormones; Humans; Male; Middle Aged; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Treatment Outcome | 1993 |
[Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Castration; Chlormadinone Acetate; Cisplatin; Combined Modality Therapy; Diethylstilbestrol; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Progesterone Congeners; Prognosis; Prostatic Neoplasms; Retrospective Studies | 1996 |
[Studies on changes in the ratio of free to total PSA after endocrine treatment of prostate carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Chlormadinone Acetate; Drug Therapy, Combination; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Immunoradiometric Assay; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Reagent Kits, Diagnostic | 1996 |
Preoperative endocrine therapy for clinical stage A2, B, and C prostate cancer: an interim report on short-term effects. Prostate Cancer Study Group.
Topics: Aged; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Humans; Leuprolide; Lymph Node Excision; Male; Multivariate Analysis; Neoplasm Staging; Preoperative Care; Progesterone Congeners; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Time Factors; Treatment Outcome | 1997 |
[Clinical study on chlormadinone acetate alone followed by combination with LH-RH analogue for prostatic cancer: effects on lipid metabolism].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Apolipoproteins; Chlormadinone Acetate; Cholesterol; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leuprolide; Lipid Metabolism; Male; Middle Aged; Progesterone Congeners; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Triglycerides | 1998 |
[Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
Topics: Aged; Androgen Antagonists; Chlormadinone Acetate; Drug Administration Schedule; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Progesterone Congeners; Prostatic Neoplasms; Testosterone | 1998 |
Early results of radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation. The Prostate Cancer Study Group.
Topics: Aged; Aged, 80 and over; Androgens; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Chlormadinone Acetate; Disease-Free Survival; Drug Therapy, Combination; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Progesterone Congeners; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Treatment Outcome | 1999 |
Prevention of the initial testosterone surge induced by a luteinizing hormone-releasing hormone analogue in prostate cancer patients: the endocrinological effects of pretreatment with chlormadinone acetate.
Topics: Administration, Oral; Aged; Chlormadinone Acetate; Drug Interactions; Drug Therapy, Combination; GABA Modulators; Gonadotropin-Releasing Hormone; Humans; Injections; Male; Middle Aged; Progesterone Congeners; Prostatic Neoplasms; Testosterone; Treatment Outcome | 1999 |
Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Diethylstilbestrol; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Survival Rate | 1999 |
[Endocrine therapy of stage D2 prostate cancer--comparison of drugs used for total androgen blockade].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Castration; Chlormadinone Acetate; Combined Modality Therapy; Disease-Free Survival; Drug Therapy, Combination; Estrogens; Flutamide; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Survival Rate; Triptorelin Pamoate | 2000 |
Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: a prospective and randomized study. The Prostate Cancer Study Group.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Disease-Free Survival; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Prospective Studies; Prostatic Neoplasms | 2000 |
Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Autacoids; Chlormadinone Acetate; Diethylstilbestrol; Humans; Leuprolide; Luteinizing Hormone; Male; Middle Aged; Neoplasm Recurrence, Local; Premedication; Progesterone Congeners; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 2000 |
A prospective randomized multicenter study of chlormadinone acetate versus flutamide in total androgen blockade for prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Enzyme Inhibitors; Flutamide; Humans; Liver; Male; Prospective Studies; Prostatic Neoplasms | 2000 |
[Treatment of newly diagnosed stage D2 prostatic carcinoma with hormonal therapy alone, or chemotherapy agents in combination with hormones].
Topics: Administration, Oral; Aged; Aged, 80 and over; Castration; Chlormadinone Acetate; Combined Modality Therapy; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Estramustine; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Survival Rate | 1991 |
66 other study(ies) available for chlormadinone acetate and Prostatic Neoplasms
| Article | Year |
|---|---|
Conditional PTEN-deficient mice as a prostate cancer chemoprevention model.
Topics: Adenocarcinoma; Androgen Antagonists; Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Chemoprevention; Chlormadinone Acetate; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostatic Neoplasms; PTEN Phosphohydrolase; Urogenital System | 2015 |
[Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Combined Modality Therapy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Prostatic Neoplasms | 2009 |
Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: a single-center experience.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Cohort Studies; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Therapy, Combination; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Risk Assessment; Survival Analysis; Tosyl Compounds; Treatment Failure | 2010 |
Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chlormadinone Acetate; Disease-Free Survival; Flutamide; Follow-Up Studies; Goserelin; Humans; Japan; Kaplan-Meier Estimate; Leuprolide; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Tosyl Compounds; Treatment Outcome | 2011 |
Neoadjuvant hormonal therapy prior to radical prostatectomy: evaluation of pathological downstaging and biochemical relapse.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Flutamide; Humans; Leuprolide; Male; Middle Aged; Neoadjuvant Therapy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2002 |
Prognostic significance of changes in short-term prostate volume and serum prostate-specific antigen after androgen withdrawal in men with metastatic prostate cancer.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Diethylstilbestrol; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Multivariate Analysis; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms | 2003 |
Tissue factor expression and prognosis in patients with metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Chlormadinone Acetate; Diethylstilbestrol; Gene Expression Regulation, Neoplastic; Humans; Life Tables; Male; Middle Aged; Neoplasm Proteins; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Survival Analysis; Thromboplastin | 2003 |
Intracranial metastatic prostate carcinoma presenting as intermittent double vision.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Diplopia; Humans; Leuprolide; Magnetic Resonance Angiography; Male; Pituitary Neoplasms; Prostatic Neoplasms; Remission Induction | 2004 |
Pure red cell aplasia in a prostate cancer patient treated with leuprolide acetate and chlormadinone acetate.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Drug Therapy, Combination; Erythrocyte Transfusion; Humans; Leuprolide; Male; Prostatic Neoplasms; Radiotherapy, Adjuvant; Red-Cell Aplasia, Pure | 2005 |
Complete response, as determined by prostate-specific antigen level, to chlormadinone acetate withdrawal persisting longer than 2 years in patients with advanced prostate cancer: two case reports.
Topics: Aged; Androgen Antagonists; Chlormadinone Acetate; Humans; Male; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Rate | 2006 |
Local injection of a sustained-release antiandrogen formulation into a target prostatic site: an experimental study.
Topics: Androgen Antagonists; Animals; Chlormadinone Acetate; Delayed-Action Preparations; Injections; Male; Organ Size; Prostatic Neoplasms; Rats | 2007 |
[Giant prostate carcinoma treated effectively with endocrine therapy: case report].
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Drug Administration Schedule; Drug Therapy, Combination; Goserelin; Humans; Magnetic Resonance Imaging; Male; Naphthalenes; Nitriles; Piperazines; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2007 |
Fate of seminal vesicles and prostate after medical castration: how long is the optimal duration of neoadjuvant treatment for prostate cancer before radiation?
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Case-Control Studies; Castration; Chlormadinone Acetate; Gonadotropin-Releasing Hormone; Humans; Male; Neoadjuvant Therapy; Neoplasm Staging; Organ Size; Prostate; Prostatic Neoplasms; Seminal Vesicles; Time Factors; Treatment Outcome; Ultrasonography | 2008 |
Negative feedback effects of chlormadinone acetate and ethynylestradiol on gonadotropin secretion in patients with prostatic cancer and male rats.
Topics: Aged; Animals; Castration; Chlormadinone Acetate; Ethinyl Estradiol; Feedback; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypothalamus; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Rats | 1980 |
[The clinical effect of chlormadinone acetate on carcinoma of the prostate (author's transl)].
Topics: Administration, Oral; Aged; Chlormadinone Acetate; Estrogens; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1980 |
[High-dose chlormadinone in the treatment of malignant tumors. An analysis of 20 cases (author's transl)].
Topics: Aged; Breast Neoplasms; Chlormadinone Acetate; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasms; Prostatic Neoplasms | 1980 |
Analysis of the efficacy of standard anticancer therapies in Japan.
Topics: Androgen Antagonists; Chlormadinone Acetate; Humans; Japan; Male; Prostatic Neoplasms | 1981 |
[Prostate cancer].
Topics: Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Estrogens; Humans; Male; Prostatectomy; Prostatic Neoplasms; Radiotherapy Dosage | 1984 |
An inhibitory effect of TZP-4238 on the growth of androgen-sensitive rat prostatic tumor (Dunning R3327).
Topics: Administration, Oral; Androgen Antagonists; Androgens; Animals; Chlormadinone Acetate; Dihydrotestosterone; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Organ Size; Prostate; Prostatic Neoplasms; Rats; Testis; Testosterone | 1993 |
Antiandrogen withdrawal syndrome in prostate cancer after treatment with steroidal antiandrogen chlormadinone acetate.
Topics: Aged; Aged, 80 and over; Chlormadinone Acetate; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome | 1995 |
Chlormadinone acetate withdrawal syndrome under combined androgen blockade for advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Chlormadinone Acetate; Gonadotropin-Releasing Hormone; Humans; Male; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1995 |
[Sequential hormone and radiation therapy for stage D1 prostate cancer].
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Chlormadinone Acetate; Diethylstilbestrol; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Survival Rate | 1993 |
[Clinical studies of newly diagnosed prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Chlormadinone Acetate; Combined Modality Therapy; Cyclophosphamide; Diethylstilbestrol; Humans; Male; Progesterone Congeners; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Survival Rate | 1996 |
Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.
Topics: Aged; Amino Acid Sequence; Androgen Antagonists; Chlormadinone Acetate; Codon; Genes; Genetic Variation; Humans; Male; Mutation; Orchiectomy; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Substance Withdrawal Syndrome | 1996 |
[Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Combined Modality Therapy; Diethylstilbestrol; Humans; Male; Middle Aged; Progesterone Congeners; Prognosis; Prostatic Neoplasms; Radiotherapy Dosage; Survival Rate | 1996 |
Effects of chlormadinone acetate and ethinylestradiol treatment on epididymal 5 alpha-reductase activities in patients with prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epididymis; Ethinyl Estradiol; Finasteride; Humans; Male; Orchiectomy; Prostatic Neoplasms | 1997 |
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.
Topics: Acid Phosphatase; Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chlormadinone Acetate; Cisplatin; Disease Progression; Estrogens; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Imidazolidines; Karnofsky Performance Status; Lactates; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Orchiectomy; Progesterone Congeners; Prognosis; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Survival Rate | 1997 |
[Prostate cancer associated with long-term intake of patent medicine containing methyltestosterone: a case report].
Topics: Aged; Biomarkers, Tumor; Chlormadinone Acetate; Combined Modality Therapy; Humans; Luteinizing Hormone; Male; Methyltestosterone; Nonprescription Drugs; Orchiectomy; Progesterone Congeners; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Testosterone Congeners | 1997 |
Response of prostate-specific antigen after androgen withdrawal and prognosis in men with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Androgens; Blood Chemical Analysis; Bone Neoplasms; Chlormadinone Acetate; Diethylstilbestrol; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate | 1998 |
Prognostic value of the serum levels of bone formation and bone resorption markers in prostate cancer patients with bone metastasis.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Bone Resorption; Chlormadinone Acetate; Collagen; Collagen Type I; Estrogens; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Peptide Fragments; Peptides; Procollagen; Progesterone Congeners; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms | 1998 |
Incidence and characteristics of antiandrogen withdrawal syndrome in prostate cancer after treatment with chlormadinone acetate.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Treatment Outcome | 1998 |
The prognosis of stage A patients treated with the antiandrogen chlormadinone acetate.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Chlormadinone Acetate; Disease Progression; Disease-Free Survival; Follow-Up Studies; Humans; Male; Middle Aged; Progesterone Congeners; Prognosis; Prostatic Neoplasms; Retrospective Studies; Survival Rate | 1999 |
Effects of intravenous administration of high dose-diethylstilbestrol diphosphate on serum hormonal levels in patients with hormone-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Chlormadinone Acetate; Dehydroepiandrosterone Sulfate; Diethylstilbestrol; Drug Resistance, Neoplasm; Estradiol; Follicle Stimulating Hormone; Goserelin; Hormones; Humans; Hydrocortisone; Leuprolide; Male; Middle Aged; Progesterone Congeners; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1999 |
[Preventive effect of chlormadinone acetate on flare-up phenomenon in advanced prostate cancer administered with a luteinizing hormone-releasing hormone analogue].
Topics: Acute-Phase Reaction; Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Chlormadinone Acetate; Drug Therapy, Combination; Humans; Luteinizing Hormone; Male; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 2000 |
[Long-term survival of hormone-refractory prostate cancer: a case report].
Topics: Adenocarcinoma; Administration, Oral; Aged; Androgen Antagonists; Chlormadinone Acetate; Combined Modality Therapy; Enzyme Inhibitors; Humans; Male; Orchiectomy; Prostatic Neoplasms; Survivors; Tegafur; Uracil | 2001 |
[Local staging with magnetic resonance imaging after neoadjuvant hormonal therapy for prostate cancer].
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Flutamide; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2001 |
Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Anilides; Antineoplastic Agents, Hormonal; Bone Neoplasms; Chlormadinone Acetate; Diethylstilbestrol; Disease Progression; Flutamide; Gonadotropin-Releasing Hormone; Humans; Japan; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Statistics, Nonparametric; Testosterone; Tosyl Compounds | 2002 |
Physiologic basis for hormonal theapy in carcinoma of the prostate.
Topics: Adrenalectomy; Androgen Antagonists; Androgens; Animals; Castration; Chemical Phenomena; Chemistry; Chlormadinone Acetate; Cyproterone; Depression, Chemical; Dihydrotestosterone; Estrogens; Hormones; Humans; Hypophysectomy; Luteinizing Hormone; Male; Prostate; Prostatic Neoplasms; Testosterone | 1975 |
[Therapeutic use of chlormadinone acetate in prostatic neoplasms].
Topics: Aged; Chlormadinone Acetate; Humans; Male; Middle Aged; Prostatic Neoplasms | 1977 |
[Effects of chlormadinone acetate therapy of prostatic neoplasms on liver functions, total serum cholesterol and triglycerides].
Topics: Aged; Chlormadinone Acetate; Cholesterol; Humans; Liver; Male; Middle Aged; Prostatic Neoplasms; Triglycerides | 1977 |
[Effects of chlormadinone acetate therapy on the pituitary-testicular system in prostatic cancer].
Topics: Chlormadinone Acetate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Pituitary Gland, Anterior; Prostatic Neoplasms; Testis; Testosterone | 1977 |
Dural arteriovenous malformation and sinus thromboses in a patient with prostate cancer: an autopsy case.
Topics: Adenocarcinoma; Aged; Angiography; Brain; Chlormadinone Acetate; Coma; Humans; Intracranial Arteriovenous Malformations; Male; Prostatic Neoplasms; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed; Vision Disorders | 1992 |
Computed tomographic evaluation of bone metastases in prostatic cancer patients.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Chlormadinone Acetate; Diagnosis, Differential; Estramustine; False Positive Reactions; Follow-Up Studies; Humans; Male; Middle Aged; Osteolysis; Prostatic Neoplasms; Radionuclide Imaging; Spinal Diseases; Spinal Neoplasms; Tomography, X-Ray Computed | 1992 |
Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Chlormadinone Acetate; Combined Modality Therapy; Estrogens; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Orchiectomy; Osteoblasts; Osteolysis; Osteosclerosis; Prostatic Neoplasms; Radiography; Treatment Outcome | 1992 |
[Papillary adenocarcinoma of the prostate with good response to antiandrogen therapy and delayed radiotherapy: a case report].
Topics: Adenocarcinoma, Papillary; Aged; Androgen Antagonists; Chlormadinone Acetate; Combined Modality Therapy; Diethylstilbestrol; Humans; Male; Prostatic Neoplasms; Remission Induction | 1992 |
[Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
Topics: Adenocarcinoma; Aged; Castration; Chlormadinone Acetate; Combined Modality Therapy; Estrogens; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Survival Rate; Time Factors | 1990 |
[Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Aged, 80 and over; Chlormadinone Acetate; Combined Modality Therapy; Diethylstilbestrol; Hemoglobins; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prognosis; Prostatic Neoplasms; Retrospective Studies; Survival Rate | 1991 |
[Promotional effects of high fat diet on chemical carcinogenesis of the prostate].
Topics: Adenocarcinoma; Aminobiphenyl Compounds; Animals; Carcinogens; Chlormadinone Acetate; Dietary Fats; Male; Mice; Mice, Inbred C3H; Prostatic Neoplasms; Rats; Rats, Inbred F344 | 1991 |
[Histological effects of hormono-chemotherapy on prostatic cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Chlormadinone Acetate; Combined Modality Therapy; Diethylstilbestrol; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Remission Induction | 1991 |
[Prostate cancer--treatment of hormone independent cancer].
Topics: Analgesics; Androgen Antagonists; Castration; Chlormadinone Acetate; Drug Resistance; Humans; Male; Prognosis; Prostatic Neoplasms | 1991 |
[Hormonal treatment of carcinoma of the prostate].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Chlormadinone Acetate; Combined Modality Therapy; Diethylstilbestrol; Drug Administration Schedule; Estramustine; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms; Survival Rate | 1991 |
[Treatment of stage D prostate cancer patients with hormones in combination with cyclophosphamide].
Topics: Adenocarcinoma; Aged; Chlormadinone Acetate; Cyclophosphamide; Diethylstilbestrol; Drug Therapy, Combination; Estramustine; Hormones; Humans; Male; Middle Aged; Prostatic Neoplasms | 1986 |
[Clinical evaluation of CMA in the treatment of prostatic cancer].
Topics: Aged; Aged, 80 and over; Chlormadinone Acetate; Combined Modality Therapy; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Testosterone | 1986 |
[Hormone therapy of male genital cancer (prostatic cancer)].
Topics: Buserelin; Chlormadinone Acetate; Estramustine; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nitrogen Mustard Compounds; Prostatic Neoplasms | 1987 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
[Hormonal environment following treatment with a small dose of estrogen--small dose of estrogen alone and in combination with an anti-androgen].
Topics: Aged; Aged, 80 and over; Chlormadinone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Prolactin; Prostatic Neoplasms; Testosterone | 1987 |
Sequential changes in the prostate of rats treated with chlormadinone acetate, testosterone and N-nitroso-N-methylurea.
Topics: Adenocarcinoma; Animals; Chlormadinone Acetate; Male; Methylnitrosourea; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone; Time Factors | 1988 |
[Endocrine therapy of stage D2 prostatic carcinoma].
Topics: Aged; Castration; Chlormadinone Acetate; Diethylstilbestrol; Estrogens; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms | 1988 |
Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Topics: Androgens; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Mice; Progesterone Congeners; Prostatic Neoplasms | 1988 |
[Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma].
Topics: Adrenocorticotropic Hormone; Back Pain; Bone and Bones; Bone Neoplasms; Chlormadinone Acetate; Dehydroepiandrosterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging | 1989 |
[Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate].
Topics: Aged; Aged, 80 and over; Antithrombin III; Chlormadinone Acetate; Diethylstilbestrol; Estrogens; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms | 1989 |
[Treatment of prostatic incidental carcinoma].
Topics: Aged; Aged, 80 and over; Chlormadinone Acetate; Follow-Up Studies; Humans; Lymph Node Excision; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms | 1989 |
[Hormone therapy of prostatic neoplasms].
Topics: Androgen Antagonists; Carcinoma; Chlormadinone Acetate; Estrogens; Humans; Long-Term Care; Male; Megestrol; Middle Aged; Prognosis; Prostatic Neoplasms; Testosterone | 1971 |
[Treatment of the carcinoma of the prostate with gestagens (author's transl)].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Carcinoma; Chlormadinone Acetate; Estrogens; Evaluation Studies as Topic; Humans; Male; Medroxyprogesterone; Megestrol; Progesterone; Prostatic Neoplasms | 1973 |
[Proceedings: Treatment of prostatic cancer with chlormadinone acetate. 1. The effect on testosterone dynamics].
Topics: Chlormadinone Acetate; Humans; Male; Prostatic Neoplasms; Testosterone | 1974 |
Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.
Topics: 17-Ketosteroids; Adrenal Glands; Animals; Carcinoma; Chlormadinone Acetate; Estrogens; Gonadotropins, Pituitary; Gonads; Hydroxyprogesterones; Luteinizing Hormone; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1967 |